New York Life Investment Management LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1133639
New York, NY
Position in NBIX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,499,785
+$604,310 QoQ
Shares Held
14,832
+3.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#285
of 768 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026New York Life Investment Management LLC holds $14,583,179 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (17.1% of the industry book) .
All Filings in NBIX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,499,785 | 14,832 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,895,475 | 14,388 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,351,498 | 9,529 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,437,070 | 10,237 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,330,931 | 10,589 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,215,715 | 10,992 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,500,681 | 10,994 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,461,220 | 12,682 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,685,769 | 12,245 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,505,396 | 10,915 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,473,472 | 11,183 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,222,650 | 10,868 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $512,331 | 5,433 | Shares | Sole | 2023-08-07 | |
| No filing history on record for this holder in this stock. | ||||||